Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
This is an infographic that is part of a new ACC campaign targeting patients amid the COVID-19 pandemic, encourage anyone with heart attack and stroke symptoms to go to the hospital. There has been a major drop in these cases from normal levels since the start of COVID-19.
Feature | Coronavirus (COVID-19) | April 14, 2020
April 14, 2020 — Since the start of COVID-19 containment efforts across the U.S. in March 2020, there has been a...
Videos | Coronavirus (COVID-19) | April 14, 2020
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and...
Videos | Coronavirus (COVID-19) | April 10, 2020
Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases. William O’Neill, M.D.,...
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC...
Feature | Heart Valve Technology | April 09, 2020
April 9, 2020 — Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European...
News | Cath Lab | April 07, 2020
April 7, 2020 — Boston Scientific Corp. is recalling its Imager II 5 French angiographic catheters, because there is a...
An ECMO cannula being inserted into a cardiovascular patient in need of mechanical oxygenation and hemodynamic support at Tufts Medical Center in December 2019. The FDA just made a temporary approval to use ECMO support in COVID-19 patients during the pandemic emergency. Photo by Dave Fornell.
Feature | Coronavirus (COVID-19) | April 07, 2020 | Dave Fornell, Editor
April 7, 2020 — The U.S. Food and Drug Administration (FDA) has issued guidance to provide a policy to help expand the...
COVID-19 by far was the largest driver of DAIC website traffic in March 2020. Clinicians quickly wanted to access information on the disease and its relation to cardiology as it rapidly spread across the United States and Europe just within the four weeks of March. DAIC has created a channel page for COVID-19 content.
Feature | April 06, 2020 | Dave Fornell, Editor
April 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
A CDC image of the novel coronavirus (COVID-10) SCAI and CAIC have created a registry to investigate the cardiovascular impact of the virus.
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of...
Videos | Structural Heart | April 03, 2020
Basel Ramlawi, M.D., chairman of The Heart and Vascular Center at Valley Health System in Virginia, director of the...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell
Feature | Interventional Radiology | April 03, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and...
News | Renal Denervation | April 01, 2020
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had...
News | Renal Denervation | April 01, 2020
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had...
Videos | Structural Heart | April 01, 2020
A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line, Baylor Scott...
The Edwards Lifesciences Cardioband for tricuspid valve regurgitation is one of the device trials being paused for the duration of the COVID-19 outbreak.
News | Heart Valve Technology | March 30, 2020
March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal...
